≡

Multiplex Assay Kit for Secretory Leukocyte Peptidase Inhibitor (SLPI) ,etc. by FLIA (Flow Luminescence Immunoassay)

ALK1; ALP; MPI; BLPI; HUSI; HUSI-I; WAP4; WFDC4; Antileukoproteinase; Seminal proteinase inhibitor; Mucus proteinase inhibitor; WAP four-disulfide core domain protein 4

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Secretory Leukocyte Peptidase Inhibitor (SLPI) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Secretory Leukocyte Peptidase Inhibitor (SLPI) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Secretory Leukocyte Peptidase Inhibitor (SLPI) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Secretory Leukocyte Peptidase Inhibitor (SLPI) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 94-101 97
EDTA plasma(n=5) 79-105 101
heparin plasma(n=5) 83-95 92
sodium citrate plasma(n=5) 82-97 89

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Secretory Leukocyte Peptidase Inhibitor (SLPI) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Secretory Leukocyte Peptidase Inhibitor (SLPI) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Secretory Leukocyte Peptidase Inhibitor (SLPI) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 79-101% 94-103% 80-91% 85-93%
EDTA plasma(n=5) 79-102% 82-98% 80-95% 79-93%
heparin plasma(n=5) 98-105% 94-105% 91-101% 89-97%
sodium citrate plasma(n=5) 88-102% 85-102% 88-102% 85-98%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:SLPI) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Human Immunology Serum alarm antiproteases in systemic sclerosis patients pubmed:28606626
The Journal of Toxicological Sciences Editor's Highlight: Candidate Risk Factors and Mechanisms for Tolvaptan-Induced Liver Injury Are Identified Using a Collaborative Cross Approach pubmed:28115652
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB312Hu01 Recombinant Secretory Leukocyte Peptidase Inhibitor (SLPI) Positive Control; Immunogen; SDS-PAGE; WB.
PAB312Hu01 Polyclonal Antibody to Secretory Leukocyte Peptidase Inhibitor (SLPI) WB; IHC; ICC; IP.
MAB312Hu22 Monoclonal Antibody to Secretory Leukocyte Peptidase Inhibitor (SLPI) WB; IHC; ICC; IP.
SEB312Hu ELISA Kit for Secretory Leukocyte Peptidase Inhibitor (SLPI) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB312Hu Multiplex Assay Kit for Secretory Leukocyte Peptidase Inhibitor (SLPI) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.